Compositions for preparation of aqueous solutions of low valence .sup.99
technitium salts
    7.
    发明授权
    Compositions for preparation of aqueous solutions of low valence .sup.99 technitium salts 失效
    用于制备低价(hu 99 {b锝盐)的水溶液的组合物

    公开(公告)号:US4104366A

    公开(公告)日:1978-08-01

    申请号:US725883

    申请日:1976-09-23

    摘要: Aqueous solutions of .sup.99 technetium salts wherein the .sup.99 technetium is in reduced valencey state, when administered to mammals, permit identification of the skeleton and of calcareous tumors by scintigraphy (radiographic scanning). The solutions are conveniently prepared by mixing one or more phosphonic acids (or their salts) with one or more reducing salts, and adding the mixture to an aqueous solution of a pharmaceutically acceptable .sup.99 pertechnetate salt. Reduction of the valence of the technetium occurs rapidly, and the resulting solution is adequately stable for use in scintigraphy.The phosphonic acid and reducing salt components can be premixed. Aqueous solutions of the premix are stable for long periods of time in the absence of free oxygen and the premix is stable to air so long as it is dry.

    摘要翻译: 99技术盐的水溶液,其中99technetium处于降低的价态,当施用于哺乳动物时,允许通过闪烁扫描(放射照相扫描)鉴定骨骼和钙质肿瘤。 通过将一种或多种膦酸(或其盐)与一种或多种还原盐混合并将混合物加入到药学上可接受的99-高辛酸盐的水溶液中,方便地制备溶液。 锝的化合价的降低迅速发生,所得溶液在闪烁扫描中的应用是稳定的。

    Medicament/dosimeter combination packaging
    9.
    发明申请
    Medicament/dosimeter combination packaging 审中-公开
    药物/剂量计组合包装

    公开(公告)号:US20060062733A1

    公开(公告)日:2006-03-23

    申请号:US10528783

    申请日:2003-09-24

    IPC分类号: A61K49/00

    摘要: In a system for individual dosing of a medicament, in accordance with the individual pathological properties (“fingerprint”) of a patient—corresponding physiologically or genetically to the disease status—two components are provided: a medicament that is to be taken or administered in a variable individual dosage and a miniaturized indicator system that obtains information from blood, saliva or other bodily fluids and tissues of the patient and displays the information in a readable form so that the patient or the treating physician can immediately read the optimal active substance to be taken or dosage to be administered.

    摘要翻译: 在用于单独给药药物的系统中,根据患者的个体病理特性(“指纹图谱”),其对应于生理或遗传上与疾病状态 - 提供了两种成分:药物,其被采取或施用于 可变个体剂量和小型化指示器系统,其从血液,唾液或患者的其他体液和组织获得信息,并以可读形式显示信息,以使患者或治疗医师能够立即将最佳活性物质读取为 服用或剂量。